| USD millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.3 | 11.4 | 11.1 | 10.7 | 12.1 | 12.6 | +4.2% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 12.3 | 11.4 | 11.1 | 10.7 | 12.1 | 12.6 | +4.2% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.6 | 1.8 | 1.5 | 1.8 | 2.0 | 1.7 | −16.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 2.6 | 3.3 | 24.1 | 12.4 | 13.6 | 38.8 | +185.6% | |
| Operating income | 10.6 | 9.6 | 9.6 | 8.9 | 10.1 | 11.0 | +8.3% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | −12.3% | |
| Other income / expense | (1.0) | (1.5) | 25.7 | (10.6) | (11.6) | (37.1) | −220.3% | |
| Pre-tax income | 9.6 | 8.1 | 35.3 | (1.8) | (1.5) | (26.1) | −1701.6% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | 9.6 | 8.1 | 35.3 | (1.8) | (1.5) | (26.1) | −1701.6% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | 0.34 | 0.29 | 1.26 | (0.06) | (0.04) | (0.79) | −1703.7% | |
| EPS, diluted (per share) | 0.34 | 0.29 | 1.26 | (0.06) | (0.04) | (0.79) | −1703.7% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 86.9% | 84.4% | 86.2% | 83.0% | 83.6% | 86.9% | +3.3 pts | |
| Net margin | 78.5% | 71.2% | 316.3% | −16.7% | −12.0% | −206.7% | −194.8 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
